Antibody Validation Market - Top Companies and Manufacturers

  • Report ID: 5010
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Companies Dominating the Antibody Validation Landscape

    • General Electric
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • F. Hoffmann La-Roche Ltd
    • Rockland Immunochemicals Inc.
    • Johnson & Johnson private Limited
    • Agilent Technologies Inc.
    • Eli Lily and Company
    • Becton, Dickinson and Company 
    • Danaher

Browse Key Market Insights with Data Illustration:

In the News

  • Leading science and technology company Merck KGaA revealed that its Life Science division's ZooMAb recombinant antibody platform has been granted an Accountability, Consistency, and Transparency (ACT) label by My Green Lab, a non-profit devoted to fostering a culture of sustainability in science.
  • Thermo Fisher Scientific Inc. has released two new SARS-CoV-2 antibody tests: The Thermo Scientific OmniPATH COVID-19 Total Antibody ELISA test and the Thermo Scientific EliA SARS-CoV-2-Sp1 IgG test. Thermo Fisher Scientific Inc. is the world leader in providing science services.

Author Credits:  Radhika Pawar


  • Report ID: 5010
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of antibody validation is evaluated at USD 476.39 billion.

The antibody validation market size was over USD 387.49 billion in 2024 and is poised to exceed USD 2.03 trillion by 2037, growing at over 13.6% CAGR during the forecast period i.e., between 2025-2037. The market growth is driven by growing prevalence of autoimmune disease, the rise in the need for early detection of cancer, and the advancement of strategies.

North America industry is predicted to dominate majority revenue share of 30% by 2037, backed by growing prevalence of HIV, along with rising investment in research and development.

The major players in the market are General Electric, Merck KGaA, Thermo Fisher Scientific Inc., F. Hoffmann La-Roche Ltd, Rockland Immunochemicals Inc., Johnson & Johnson private Limited, Agilent Technologies Inc., Eli Lily and Company, Becton, Dickinson and Company, Danaher
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample